VASCOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vascor, and when can generic versions of Vascor launch?
Vascor is a drug marketed by Johnson And Johnson and Mallinckrodt and is included in two NDAs.
The generic ingredient in VASCOR is iothalamate meglumine; iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate meglumine; iothalamate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VASCOR?
- What are the global sales for VASCOR?
- What is Average Wholesale Price for VASCOR?
Summary for VASCOR
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 31 |
Clinical Trials: | 1 |
Patent Applications: | 720 |
DailyMed Link: | VASCOR at DailyMed |
Recent Clinical Trials for VASCOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Poznan University of Medical Sciences | Phase 3 |
US Patents and Regulatory Information for VASCOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-001 | Dec 28, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mallinckrodt | VASCORAY | iothalamate meglumine; iothalamate sodium | INJECTABLE;INJECTION | 016783-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-002 | Dec 28, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-003 | Dec 28, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VASCOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-001 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-003 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Johnson And Johnson | VASCOR | bepridil hydrochloride | TABLET;ORAL | 019002-002 | Dec 28, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VASCOR
See the table below for patents covering VASCOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S4899127 | ⤷ Sign Up | |
France | 2174655 | ⤷ Sign Up | |
United Kingdom | 1377327 | ⤷ Sign Up | |
Spain | 412203 | ⤷ Sign Up | |
Canada | 1015360 | ETHYLENEDIAMINES SUBSTITUEES A ACTIVITE CARDIOVASCULAIRE | ⤷ Sign Up |
Netherlands | 153190 | ⤷ Sign Up | |
South Africa | 7301411 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |